Literature DB >> 29383448

A comparison of CRISPR/Cas9 and siRNA-mediated ALDH2 gene silencing in human cell lines.

Fei Wang1, Tao Guo1, Hongmei Jiang1, Ruobi Li1, Ting Wang1, Ni Zeng1, Guanghui Dong1, Xiaowen Zeng1, Daochuan Li1, Yongmei Xiao1, Qiansheng Hu1, Wen Chen1, Xiumei Xing2, Qing Wang3.   

Abstract

Gene knockdown and knockout using RNAi and CRISPR/Cas9 allow for efficient evaluation of gene function, but it is unclear how the choice of technology can influence the results. To compare the phenotypes obtained using siRNA and CRISPR/Cas9 technologies, aldehyde dehydrogenase 2 (ALDH2) was selected as an example. In this study, we constructed one HepG2 cell line with a homozygous mutation in the fifth exon of ALDH2 (ALDH2-KO1 cell) using the eukaryotic CRISPR/Cas9 expression system followed by the limited dilution method and one HepG2 cell line with different mutations in the ALDH2 gene (ALDH2-KO2 cell) using the lentivirus CRISPR/Cas9 system. Additionally, one ALDH2-knockdown (KD) HepG2 cell line was created using siRNA. The reproducibility of these methods was further verified in the HEK293FT cell line. We found that the mRNA expression level of ALDH2 was significantly decreased and the protein expression level of ALDH2 was completely abolished in the ALDH2-KO cell lines, but not in ALDH2-KD cells. Furthermore, the functional activity of ALDH2 was also markedly disrupted in the two ALDH2-KO cell lines compared with ALDH2-KD and wild-type cells. The lack of ALDH2 expression mediated by CRIPSR/Cas9 resulted in a more dramatic increase in the cellular susceptibility to chemical-induced reactive oxygen species generation, cytotoxicity, apoptosis, and inflammation, especially at low concentrations compared with ALDH2-KD and WT cells. Therefore, we consider the gene knockout cell line created by CRISPR/Cas9 to be a more useful tool for identifying the function of a gene.

Entities:  

Keywords:  ALDH2; CRISPR/Cas9; Gene knockout; HepG2

Mesh:

Substances:

Year:  2018        PMID: 29383448     DOI: 10.1007/s00438-018-1420-y

Source DB:  PubMed          Journal:  Mol Genet Genomics        ISSN: 1617-4623            Impact factor:   3.291


  33 in total

1.  Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

Authors:  F Ann Ran; Patrick D Hsu; Chie-Yu Lin; Jonathan S Gootenberg; Silvana Konermann; Alexandro E Trevino; David A Scott; Azusa Inoue; Shogo Matoba; Yi Zhang; Feng Zhang
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

2.  Aldehyde dehydrogenase 1B1: molecular cloning and characterization of a novel mitochondrial acetaldehyde-metabolizing enzyme.

Authors:  Dimitrios Stagos; Ying Chen; Chad Brocker; Elizabeth Donald; Brian C Jackson; David J Orlicky; David C Thompson; Vasilis Vasiliou
Journal:  Drug Metab Dispos       Date:  2010-07-08       Impact factor: 3.922

3.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

4.  Aldehyde dehydrogenase 2 activity affects symptoms produced by an intraperitoneal acetaldehyde injection, but not acetaldehyde lethality.

Authors:  Toyohi Isse; Tsunehiro Oyama; Koji Matsuno; Iwao Uchiyama; Toshihiro Kawamoto
Journal:  J Toxicol Sci       Date:  2005-12       Impact factor: 2.196

5.  In vitro long-term cytotoxicity testing of 27 MEIC chemicals on Hep G2 cells and comparison with acute human toxicity data.

Authors:  E M Scheers; B Ekwall; P J Dierickx
Journal:  Toxicol In Vitro       Date:  2001-04       Impact factor: 3.500

6.  An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation.

Authors:  Zhiqiang Chen; Matthew W Foster; Jian Zhang; Lan Mao; Howard A Rockman; Toshihiro Kawamoto; Kyoko Kitagawa; Keiichi I Nakayama; Douglas T Hess; Jonathan S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

7.  Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease.

Authors:  Hannes Hagström; Patrik Nasr; Mattias Ekstedt; Stergios Kechagias; Kristina Önnerhag; Emma Nilsson; Fredrik Rorsman; Reza Sheikhi; Hanns-Ulrich Marschall; Rolf Hultcrantz; Per Stål
Journal:  Scand J Gastroenterol       Date:  2016-10-06       Impact factor: 2.423

8.  Transcriptome-wide interrogation of RNA secondary structure in living cells with icSHAPE.

Authors:  Ryan A Flynn; Qiangfeng Cliff Zhang; Robert C Spitale; Byron Lee; Maxwell R Mumbach; Howard Y Chang
Journal:  Nat Protoc       Date:  2016-01-14       Impact factor: 13.491

9.  Role of the aldehyde dehydrogenase-1 isozyme in the metabolism of acetaldehyde.

Authors:  Y Ueshima; Y Matsuda; M Tsutsumi; A Takada
Journal:  Alcohol Alcohol Suppl       Date:  1993

10.  Landscape and variation of RNA secondary structure across the human transcriptome.

Authors:  Yue Wan; Kun Qu; Qiangfeng Cliff Zhang; Ryan A Flynn; Ohad Manor; Zhengqing Ouyang; Jiajing Zhang; Robert C Spitale; Michael P Snyder; Eran Segal; Howard Y Chang
Journal:  Nature       Date:  2014-01-30       Impact factor: 49.962

View more
  4 in total

1.  Connexin 43 Hemichannels Regulate Osteoblast to Osteocyte Differentiation.

Authors:  Rui Hua; Sumin Gu; Jean X Jiang
Journal:  Front Cell Dev Biol       Date:  2022-05-27

Review 2.  The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer.

Authors:  Jiayu Zhang; Wenlong Zhou; Xiaoxuan Wang; Lihui Wang
Journal:  RSC Adv       Date:  2018-09-28       Impact factor: 4.036

3.  CRISPR-based engineering of gene knockout cells by homology-directed insertion in polyploid Drosophila S2R+ cells.

Authors:  Baolong Xia; Gabriel Amador; Raghuvir Viswanatha; Jonathan Zirin; Stephanie E Mohr; Norbert Perrimon
Journal:  Nat Protoc       Date:  2020-09-21       Impact factor: 13.491

4.  ATPIF1 maintains normal mitochondrial structure which is impaired by CCM3 deficiency in endothelial cells.

Authors:  Kang Wang; Haixuan Chen; Zhongyang Zhou; Haifeng Zhang; Huanjiao Jenny Zhou; Wang Min
Journal:  Cell Biosci       Date:  2021-01-09       Impact factor: 7.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.